| scholarly article | Q13442814 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Donald E White | |
| James C Yang | |||
| Peter A Prieto | |||
| Richard M Sherry | |||
| Russell C Langan | |||
| Gyorgy Csako | |||
| John Wunderlich | |||
| Rene Costello | |||
| Daniel Zlott | |||
| P2860 | cites work | Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma | Q24548019 |
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens | Q24644442 | ||
| Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study | Q33429787 | ||
| Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis | Q33805271 | ||
| Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. | Q34380985 | ||
| Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide | Q35918369 | ||
| Maintenance of ovarian function and risk of premature menopause related to cancer treatment | Q36077605 | ||
| Ovarian recovery after stem cell transplantation | Q36977555 | ||
| Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). | Q42511622 | ||
| Ovarian function preservation in patients under chemotherapy treatment | Q46287313 | ||
| Does ifosfamide affect gonadal function? | Q46921911 | ||
| Ovarian function after autologous bone marrow transplantation | Q47625360 | ||
| Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. | Q51662152 | ||
| Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer | Q67562169 | ||
| Menstrual and Hormone Patterns in Women Treated with High-Dose Cisplatin and Bleomycin | Q71647050 | ||
| Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al | Q73090838 | ||
| P433 | issue | 4 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 397-402 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy | |
| P478 | volume | 34 |
| Q40766038 | Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation |
| Q37056902 | Oncofertility in Canada: the impact of cancer on fertility |
| Q98386077 | Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2 |
| Q35223404 | Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment |
Search more.